for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

AstraZeneca working on vaccine with Oxford to target new variant, CEO says -La Repubblica

Jan 26 (Reuters) - AstraZeneca Chief Executive Pascal Soriot said on Tuesday that the British drugmaker is working with Oxford University on a vaccine that will target the South African variant of COVID-19.

"Having said that, we're also working on a vaccine with Oxford University that will target the variant," Soriot told Italian daily La Repubblica in an interview bit.ly/2KWidAc published late on Tuesday.

Reporting by Kanishka Singh in Bengaluru; Editing by Leslie Adler

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up